Radiolabeled Monoclonal Antibody With or Without Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Lymphoma

NCT00036855 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

36

Enrollment

NIH

Sponsor class

Stopped Administratively complete.

Conditions

AIDS-related Peripheral/Systemic Lymphoma
AIDS-related Primary CNS Lymphoma
Post-transplant Lymphoproliferative Disorder
Recurrent Childhood Large Cell Lymphoma
Recurrent Childhood Lymphoblastic Lymphoma
Recurrent Childhood Small Noncleaved Cell Lymphoma
Recurrent/Refractory Childhood Hodgkin Lymphoma

Interventions

BIOLOGICAL: rituximab
RADIATION: indium In 111 ibritumomab tiuxetan
RADIATION: yttrium Y 90 ibritumomab tiuxetan
PROCEDURE: peripheral blood stem cell transplantation
BIOLOGICAL: filgrastim
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)